Harvest Health and Recreation Q4 2019 Earnings a Miss
Harvest Health (CNSX: HARV, OTCMKTS: HRVSF) just posted their results for Q4 2019 and the full fiscal year. It’s not looking pretty.
Revenue came in at $37.8M which is about $2M less than analysts’ estimates of $39.45M
EBITDA came in -$6.8M which missed previous estimates of -$3.23M
Fourth Quarter and Full Year 2019 Financial Highlights:
- Total revenue in the fourth quarter was $37.8 million, an increase of 123% from $16.9 million in the fourth quarter of 2018 and up 14%, compared to $33.2 million in the third quarter of 2019. Full year revenue increased 149% to $116.8 million in 2019 compared to $47.0 million in 2018.
- Gross profit excluding biological adjustments in the fourth quarter was $16.0 million, compared to $11.6 million in the third quarter of 2019. Gross profit excluding biological adjustments for the full year was $42.2 million compared to $24.6 million in 2018.
- Gross profit margin excluding biological adjustments in the fourth quarter was 42.3%, compared to 35.0% for the third quarter of 2019. Gross profit margin excluding biological adjustments for the full year was 36.1% compared to 52.3% in 2018.
- Adjusted EBITDA excluding biological adjustments in the fourth quarter was ($6.8) million, compared to ($10.9) million in the third quarter of 2019. Adjusted EBITDA excluding biological adjustments for the full year was ($34.8) million, compared to $7.9 million in 2018.
- Net loss was $88.9 million for the fourth quarter compared to net loss of $71.1 million during the fourth quarter 2018. Net loss for the full year was $173.5 million compared to net loss of $67.5 million in 2018.
Harvest Health continues to get crushed in the markets for the past year and is now down 90% since last year. They are far from profitability and this is probably why no one is buying.
Read the Full Press Release Below:
PHOENIX, April 7, 2020 /PRNewswire/ — Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator (MSO) in the U.S., today reported its financial and operating results for the fourth quarter and year ended 2019. All financial information is provided in U.S. dollars unless otherwise indicated.
Fourth Quarter Highlights
- New capital raised by Harvest included $6.5 million of real estate backed debt, approximately $47.3 million of short-term debt, $10 million in convertible debt and $30 million in senior secured debt. During the quarter approximately $84 million of debt was exchanged into our new senior secured debt, including the short-term debt totaling approximately $47.3 million raised during the fourth quarter.
- Harvest opened four new retail locations in California and Pennsylvania and added one operational retail location in Maryland through a managed services agreement.
- Harvest was awarded one of two retail permits in Hanford, California by achieving the top score amongst all applicants.
- Founding shareholders agreed to a voluntary six-month lockup extension in November covering approximately 19.5 million shares.
- Ana Dutra and Eula Adams were appointed to the Board of Directors, adding valuable experience in financial and corporate management disciplines.
- Harvest announced the addition of Daniel Reiner as a special advisor to the board and Scott Atkison as a future board member.
- CannApprove testing and safety protocols were implemented covering THC vape products manufactured by Harvest.
Full Year Highlights
- New capital raised during 2019 included short-term debt, unsecured convertible debt, real estate backed debt, and senior secured debt totaling approximately $295 million.
- Harvest added 21 retail locations through a combination of organic store openings, acquisitions of operational retail locations, and addition of stores through managed service agreements. At year end, Harvest owned, operated, or managed 31 retail locations in six states, including 11 in Arizona.
- Harvest was awarded licenses allowing for up to 10 additional revenue generating facilities including cultivation and manufacturing facilities and retail dispensaries.
Subsequent Highlights
- New capital raised subsequent to 2019 included $20 million of real estate backed debt, $21.3 million in senior secured debt, and $59 million in equity.
- Harvest added five retail locations through a combination of organic store openings and acquisitions of operational retail locations in Arizona, Arkansas, and Michigan. As of April 3, 2020, Harvest owned, operated, or managed 35 retail locations in seven states, including 14 open dispensaries in Arizona. Harvest owned and operated dispensaries exclude retail locations serviced through Interurban Capital Group.
- Harvest completed the acquisition of Franklin Labs on March 26, 2020, adding cultivation and manufacturing capabilities to its operations in Pennsylvania. The cultivation facility is operational and manufacturing activities are expected to commence during the second quarter of 2020.
- The acquisition of Interurban Capital Group was completed on March 13, 2020, adding strategic investors to the shareholder base and direct and indirect licenses in California and Iowa and rights to acquire assets and provide cannabis retail support services for dispensaries in California, Iowa and Washington.
- The acquisition of Arizona Natural Selections was completed on February 18, 2020, adding three open retail locations, an indoor cultivation facility, greenhouse cultivation facility and potential outdoor cultivation to Harvest’s existing operational footprint in Arizona. The acquisition included a fourth vertical license in Arizona and the Darwin product line.
- Harvest announced an agreement to acquire the operations of a cultivation and manufacturing facility in Nevada from MJardin Group in January 2020.
- Harvest announced legal action seeking the termination of the merger agreement with Falcon International in January 2020.
- The company announced a mutual agreement with Verano Holdings to terminate the pending business combination agreement on March 25, 2020. No breakup fees are required by either party as part of the termination agreement.
- Three members of senior leadership surrendered 2.4 million option awards to contribute to a new equity option award totaling 3.0 million options in February 2020.
- Mark Barnard assumed the role of Chairman of the Board in March 2020.
- Ron Goodson joined Harvest as Chief Operating Officer in January 2020.
COVID-19 Update
Harvest is committed to the health and well-being of patients, customers, and the communities in which we operate. As operators of primarily medical retail dispensaries, the company is working to ensure continued service for patients in need during this challenging time. Stakeholders are encouraged to visit our microsite https://covid19.harvesthoc.com regularly for updates.
Outlook
We expect to report first quarter 2020 sequential revenue growth in line with the sequential revenue growth reported for the fourth quarter 2019.
Management Commentary
“2019 was an important investment year for our company. Harvest exited the year with a broader retail presence, expanded cultivation and manufacturing operations, and greater support infrastructure needed to achieve operational efficiencies and return to profitability. Moving forward we believe Harvest has the assets and capital required to succeed long-term in the cannabis industry,” said Chief Executive Officer Steve White.
Conference Call & Webcast
Harvest Health and Recreation Inc. will host a conference call and audio webcast with Chief Executive Officer Steve White and Chief Financial Officer Leo Jaschke, Tuesday April 7, 2020 at 5:00 PM Eastern Time.
To participate in the conference call, please dial: |
|||
US/Canada toll free: |
+ 1-844-607-4373 |
||
International dial in: |
+ 1-825-312-2262 |
||
International Toll Free Dial-In Numbers: |
|||
Australia: |
+ 1-800-287011 |
||
Hong Kong: |
+ 800-901-563 |
||
South Africa: |
+ 0-800-983-113 |
||
United Kingdom: |
+ 0-800-051-7107 |
Access the live webcast link here:
https://investor.harvesthoc.com/events-and-presentations/default.aspx
Fourth quarter results and the conference call replay will be available at:
investor.harvesthoc.com/financials
HARVEST HEALTH & RECREATION INC. |
|||||||
Consolidated Statements of Financial Position |
|||||||
December 31, 2019 and 2018 |
|||||||
(Amounts expressed in thousands of United States dollars) |
|||||||
December 31, |
December 31, |
||||||
ASSETS |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ |
22,685 |
$ |
191,883 |
|||
Restricted cash |
8,000 |
8,000 |
|||||
Accounts receivable, net |
12,147 |
2,993 |
|||||
Notes receivable, current portion |
51,349 |
13,600 |
|||||
Biological assets |
8,057 |
6,788 |
|||||
Inventory, net |
28,774 |
23,177 |
|||||
Other current assets |
4,788 |
1,810 |
|||||
Total current assets |
135,800 |
248,251 |
|||||
Notes receivable, net of current portion |
34,430 |
3,076 |
|||||
Property, plant and equipment, net |
151,050 |
31,855 |
|||||
Right-of-use asset, net |
57,288 |
— |
|||||
Intangibles assets, net |
160,114 |
112,830 |
|||||
Corporate investments |
— |
5,000 |
|||||
Acquisition deposits |
3,645 |
1,350 |
|||||
Goodwill |
84,596 |
69,407 |
|||||
Other assets |
8,641 |
6,830 |
|||||
TOTAL ASSETS |
$ |
635,564 |
$ |
478,599 |
|||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|||||||
LIABILITIES |
|||||||
Current liabilities: |
|||||||
Accounts payable |
$ |
6,969 |
$ |
4,694 |
|||
Other current liabilities |
21,944 |
6,715 |
|||||
Contingent consideration, current portion |
13,764 |
11,520 |
|||||
Income tax payable |
5,310 |
4,120 |
|||||
Lease liability, current portion |
2,885 |
— |
|||||
Notes payable, current portion |
8,395 |
11,806 |
|||||
Total current liabilities |
59,267 |
38,855 |
|||||
Notes payable, net of current portion |
202,619 |
19,098 |
|||||
Lease liability, net of current portion |
54,621 |
— |
|||||
Deferred tax liability |
28,587 |
18,173 |
|||||
Contingent consideration, net of current portion |
16,249 |
18,190 |
|||||
Other long-term liabilities |
179 |
4,486 |
|||||
TOTAL LIABILITIES |
361,522 |
98,802 |
|||||
STOCKHOLDERS’ EQUITY |
|||||||
Capital stock |
505,709 |
435,495 |
|||||
Accumulated deficit |
(235,348) |
(61,270) |
|||||
Stockholders’ equity attributed to Harvest Health & Recreation Inc. |
270,361 |
374,225 |
|||||
Non-controlling interest |
3,681 |
5,572 |
|||||
TOTAL STOCKHOLDERS’ EQUITY |
274,042 |
379,797 |
|||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ |
635,564 |
$ |
478,599 |
Consolidated Statements of Operations |
|||||||||||||||
Three Months and Years Ended December 31, 2019 and 2018 |
|||||||||||||||
(Amounts expressed in thousands of United States dollars, except share or per share data) |
|||||||||||||||
For the three months ended |
For the twelve months ended |
||||||||||||||
2019 |
2018 |
2019 |
2018 |
||||||||||||
Revenue |
$ |
37,793 |
$ |
16,943 |
$ |
116,780 |
$ |
46,955 |
|||||||
Cost of goods sold |
(21,791) |
(9,760) |
(74,573) |
(22,402) |
|||||||||||
Gross profit, before biological asset adjustments |
16,002 |
7,183 |
42,207 |
24,553 |
|||||||||||
Realized fair value amounts included in inventory sold |
(13,355) |
– |
(44,474) |
(3,559) |
|||||||||||
Unrealized fair value gain on growth of biological assets |
9,093 |
267 |
45,841 |
5,958 |
|||||||||||
Gross profit |
11,740 |
7,450 |
43,574 |
26,952 |
|||||||||||
Expenses |
|||||||||||||||
General and administrative |
27,017 |
22,900 |
98,165 |
35,658 |
|||||||||||
Sales and marketing |
2,402 |
557 |
8,939 |
1,079 |
|||||||||||
Share-based compensation expense |
(1,420) |
1,545 |
17,695 |
1,545 |
|||||||||||
Depreciation and amortization |
2,715 |
466 |
10,299 |
1,544 |
|||||||||||
Fixed and intangible asset impairments |
16,977 |
— |
16,977 |
— |
|||||||||||
Total expenses |
47,691 |
25,468 |
152,075 |
39,826 |
|||||||||||
Operating loss |
(35,951) |
(18,018) |
(108,501) |
(12,874) |
|||||||||||
Other (expense) income |
|||||||||||||||
Gain (loss) on disposal of assets |
(2,431) |
(995) |
(2,225) |
566 |
|||||||||||
Other expense |
(7,896) |
(50,716) |
(8,774) |
(50,716) |
|||||||||||
Foreign currency gain (loss) |
(469) |
512 |
(970) |
512 |
|||||||||||
Interest expense |
(7,516) |
(885) |
(16,242) |
(1,677) |
|||||||||||
Contract and other asset impairment |
(35,098) |
— |
(35,098) |
— |
|||||||||||
Loss before taxes and non-controlling interest |
(89,361) |
(70,102) |
(171,810) |
(64,189) |
|||||||||||
Income taxes |
(185) |
(1,423) |
(3,756) |
(3,877) |
|||||||||||
Loss before non-controlling interest |
(89,546) |
(71,525) |
(175,566) |
(68,066) |
|||||||||||
Loss attributed to non-controlling interest |
696 |
437 |
2,079 |
601 |
|||||||||||
Net loss attributed to Harvest Health & |
$ |
(88,850) |
$ |
(71,088) |
$ |
(173,487) |
$ |
(67,465) |
|||||||
Loss per share – basic and diluted |
$ |
(0.31) |
$ |
(0.61) |
|||||||||||
Attributable to Harvest Health and Recreation Inc. Stockholders |
$ |
(0.31) |
$ |
(0.61) |
|||||||||||
Attributable to non-controlling interest |
$ |
0.00 |
$ |
0.01 |
|||||||||||
Weighted-average shares outstanding – basic and diluted |
288,902,707 |
286,626,553 |
Non-IFRS Financial and Performance Measures
The Company provides additional financial metrics that are not prepared in accordance with IFRS. Management uses non-IFRS financial measures, in addition to IFRS financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company’s financial performance. This non-IFRS financial measure is Adjusted EBITDA.
Management believes that these non-IFRS financial measures reflect the Company’s ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. Management also believes that these non-IFRS financial measures enable investors to evaluate the Company’s operating results and future prospects in the same manner as management. These non-IFRS financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company’s ongoing operating results.
As there are no standardized methods of calculating these non-IFRS measures, the Company’s methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others. Accordingly, these non-IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.
Reconciliations of Non-IFRS Financial and Performance Measures
The table below reconciles Net Loss to Adjusted EBITDA for the periods indicated.
Three months ended |
Twelve months ended |
|||||||||||||||
2019 |
2018 |
2019 |
2018 |
|||||||||||||
Net loss (IFRS) before non-controlling interest |
$ |
(89,546) |
$ |
(71,525) |
$ |
(175,566) |
$ |
(68,066) |
||||||||
Add (deduct) impact of: |
||||||||||||||||
Net interest and other financing costs (1) |
7,679 |
885 |
16,926 |
1,677 |
||||||||||||
Income tax |
185 |
1,423 |
3,756 |
3,877 |
||||||||||||
Amortization and depreciation (2) |
3,595 |
466 |
12,693 |
1,544 |
||||||||||||
Fixed and intangible asset impairments |
16,977 |
— |
16,977 |
— |
||||||||||||
(Gain) loss on disposal of assets |
2,431 |
995 |
2,225 |
(566) |
||||||||||||
Fair value adjustment of liability |
125 |
50,716 |
488 |
50,716 |
||||||||||||
Other expense |
7,771 |
— |
8,286 |
— |
||||||||||||
Foreign currency (gain) loss |
469 |
(512) |
970 |
(512) |
||||||||||||
Share-based compensation expense |
(1,420) |
1,545 |
17,695 |
1,545 |
||||||||||||
Contract and other asset impairment |
35,098 |
— |
35,098 |
— |
||||||||||||
Realized fair value amounts included in inventory sold |
13,355 |
— |
44,474 |
3,559 |
||||||||||||
Unrealized fair value gain on growth of biological assets |
(9,093) |
(267) |
(45,841) |
(5,958) |
||||||||||||
Other expansion expenses (pre-open) |
2,658 |
5,876 |
9,770 |
5,876 |
||||||||||||
Transaction & other special charges |
2,894 |
12,760 |
17,200 |
14,174 |
||||||||||||
Adjusted EBITDA (non-IFRS) |
$ |
(6,822) |
$ |
2,362 |
$ |
(34,849) |
$ |
7,866 |
(1) Includes $162, $-, $684, and $- of interest reported in cost of sales. |
(2) Includes $879, $-, $2,394, and $- of depreciation reported in cost of sales. |
About Harvest Health & Recreation Inc.
Headquartered in Tempe, Arizona, Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator (MSO). Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S., with the potential to more than double the number of revenue generating facilities. Harvest’s mission is to improve lives through the goodness of cannabis. We hope you’ll join us on our journey: https://harvesthoc.com
Facebook: @HarvestHOC
Instagram: @HarvestHOC
Twitter: @HarvestHOC
Forward-looking Statements
This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Harvest with respect to future business activities. Forward-looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and include information regarding: (i) expectations regarding the size of the U.S. cannabis market, (ii) the ability of the Company to successfully achieve its business objectives, (iii) plans for expansion of Harvest, and (iv) expectations for other economic, business, and/or competitive factors.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflects Harvest management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Harvest believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability of Harvest to open additional retail locations and meet its revenue growth and profitability objectives, the ability of Harvest to integrate recent acquisitions, the ability of Harvest to obtain and/or maintain licenses or other contractual rights to operate in the jurisdictions in which it operates or in which it expects or plans to operate; changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of Harvest to raise debt and equity capital in the amounts needed and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that Harvest operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws, including those related to taxation; and increasing costs of compliance with extensive government regulation. This forward-looking information may be affected by risks and uncertainties in the business of Harvest and market conditions.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Harvest has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Harvest does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Additional Information
The financial information reported in this news release is based on unaudited management prepared financial statements for the quarter and year ended December 31, 2019. Accordingly, such financial information may be subject to change. Financial statements for the period will be released and filed under the Company’s profiles on SEDAR at www.SEDAR.com by April 30, 2020. All financial information contained in this news release is qualified in its entirety with reference to such unaudited financial statements. While the Company does not expect there to be any material changes, to the extent that the financial information contained in this news release is inconsistent with the information contained in the Company’s unaudited financial statements, the financial information contained in this news release shall be deemed to be modified or superseded by the Company’s unaudited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.
View original content to download multimedia:http://www.prnewswire.com/news-releases/harvest-health–recreation-inc-reports-fourth-quarter-and-full-year-2019-financial-results-301037061.html
SOURCE Harvest Health & Recreation Inc.
Harvest Health and Recreation Q4 2019 Earnings a Miss
About Cannin: Cannabis and Hemp Investment Experts
Market analysts expect the cannabis and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in cannabis and hemp stocks is now. Are you looking to buy stock in hemp companies or cannabis companies? Interested in emerging penny pot stock companies? Looking for the best Canadian pot company to invest in? Cannin is your trusted resource for information about Cannabis and Hemp stock investment opportunities. Our global team of experts evaluates emerging cannabis and hemp companies. We aggregate hundreds of hours of research and provide tips on the best cannabis and hemp stock investments for 2020. We provide the latest marijuana and hemp investment news and analysis. Visit our site for breaking cannabis investing news and featured companies, sign up for the free Cannin Chronicle or get a free trial of our smart cannabis and hemp stock algorithm to take the guesswork out of profiting from this exciting industry. Predict the price of cannabis and hemp stocks hours in advance with our proven machine learning algorithm. Is it too late to invest in marijuana companies like Harvest Health? No! Well, given the financial results, we’d hold off for now but there are plenty of other great marijuana stocks to buy for 2020. This is the perfect time to invest.
Profit from the best Cannabis and Hemp stocks – we’ll show you how at cannin.com